SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031671
Filing Date
2023-11-13
Accepted
2023-11-13 16:55:19
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20230930_10q.htm   iXBRL 10-Q 737585
2 EXHIBIT 31.1 ex_590657.htm EX-31.1 12714
3 EXHIBIT 31.2 ex_590658.htm EX-31.2 12736
4 EXHIBIT 32.1 ex_590659.htm EX-32.1 4593
5 EXHIBIT 32.2 ex_590660.htm EX-32.2 4609
11 a1.jpg GRAPHIC 32282
  Complete submission text file 0001437749-23-031671.txt   4151070

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20230930.xsd EX-101.SCH 42886
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20230930_def.xml EX-101.DEF 283981
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20230930_lab.xml EX-101.LAB 230235
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20230930_pre.xml EX-101.PRE 308103
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20230930_cal.xml EX-101.CAL 33034
58 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20230930_10q_htm.xml XML 551380
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 231399757
SIC: 2834 Pharmaceutical Preparations